Applied Imaging and Genetix Amend Merger Agreement Resulting in $4.20 Per Share Purchase Price
News Nov 13, 2006
In response to an unsolicited bid from a third party to acquire all of the outstanding securities of Applied Imaging Corp., Applied Imaging has announced that its definitive agreement to be acquired by Genetix Group plc. had been amended on November 9, 2006.
The amendment reflects an increase in the consideration payable by Genetix to Applied Imaging's stockholders from $3.80 per share to $4.20 per share.
A special meeting to approve the proposed acquisition is still expected to take place on Tuesday at 10:00 a.m. on November 21, 2006 at Applied Imaging's headquarters in San Jose, California.
Back in 2009, researchers identified a herd of Awassi sheep suffering from "day blindness". As that term implies, these sheep were blind during the day (in bright light) but could see at night, in low-light conditions. After identifying the genetic basis of this blindness, researchers have now successfully used gene therapy to restore their daytime vision.READ MORE